Company page

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (AVXL) is a public company based in the United States, focusing on the development of therapies for neurodegenerative diseases. With a market capitalization of approximately $221.5 million, Anavex is engaged in advancing its research and clinical programs. The company aims to address significant unmet medical needs in the field of neuroscience.